468 related articles for article (PubMed ID: 32037739)
1. The rapidly advancing Class 2 CRISPR-Cas technologies: A customizable toolbox for molecular manipulations.
Wang J; Zhang C; Feng B
J Cell Mol Med; 2020 Mar; 24(6):3256-3270. PubMed ID: 32037739
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
3. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
Liu T; Pan S; Li Y; Peng N; She Q
Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
[TBL] [Abstract][Full Text] [Related]
4. Controlling and enhancing CRISPR systems.
Shivram H; Cress BF; Knott GJ; Doudna JA
Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
[TBL] [Abstract][Full Text] [Related]
5. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
[TBL] [Abstract][Full Text] [Related]
6. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
Ishino Y; Krupovic M; Forterre P
J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
8. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
9. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
[TBL] [Abstract][Full Text] [Related]
10. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
11. Type II anti-CRISPR proteins as a new tool for synthetic biology.
Zhang Y; Marchisio MA
RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
[TBL] [Abstract][Full Text] [Related]
12. Exploration of Microbial Diversity to Discover Novel Molecular Technologies.
Zhang F
Keio J Med; 2019; 68(1):26. PubMed ID: 30905885
[TBL] [Abstract][Full Text] [Related]
13. Finally, Archaea Get Their CRISPR-Cas Toolbox.
Gophna U; Allers T; Marchfelder A
Trends Microbiol; 2017 Jun; 25(6):430-432. PubMed ID: 28391963
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
15. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
Swartjes T; Staals RHJ; van der Oost J
Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
[TBL] [Abstract][Full Text] [Related]
16. Characterization and applications of Type I CRISPR-Cas systems.
Hidalgo-Cantabrana C; Barrangou R
Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
[TBL] [Abstract][Full Text] [Related]
17. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
Batzir NA; Tovin A; Hendel A
Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
[TBL] [Abstract][Full Text] [Related]
19. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]